Protective action of l-carnitine on cardiac mitochondrial function and structure against fatty acid stress

• Published in: Biochemical and biophysical research communications Vol. 412; no. 1; pp. 61 - 67
• Main Authors: Oyanagi, Eri, Yano, Hiromi, Uchida, Masataka, Utsumi, Kozo, Sasaki, Junzo
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 19-08-2011
• Subjects: Animals; Carnitine - pharmacology; Cytochrome c; Fatty Acids - pharmacology; Heart; Mitochondria, Heart - ultrastructure; Mitochondrial Swelling - drug effects; Oxygen Consumption - drug effects; Palmitoyl Coenzyme A - pharmacology; Palmitoyl-CoA; Permeability - drug effects; Rats; Stress, Physiological - drug effects; Vitamin B Complex - pharmacology; β-Oxidation; Cytochrome c; Heart; Palmitoyl-CoA; β-Oxidation
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2011.07.039

► Fatty acid-induced mitochondrial membrane depolarization and swelling were greatly inhibited by the presence of
l-carnitine. ► We provide evidence of the first successful visualization of the protective action of
l-carnitine on the cardiac mitochondrial ultrastructure. ► A high
l-carnitine concentration contributes to mitochondrial membrane stabilization, along with acceleration of fatty acid β-oxidation. ►
l-Carnitine completely inhibited fatty acid-induced cytochrome
c release. ► Although cardiovascular risks are frequently accompanied by high serum fatty acid levels,
l-carnitine may attenuate the mitochondrial dysfunction and apoptosis of cardiocytes.
Cardiovascular risks are frequently accompanied by high serum fatty acid levels. Although recent studies have shown that fatty acids affect mitochondrial function and induce cell apoptosis,
l-carnitine is essential for the uptake of fatty acids by mitochondria, and may attenuate the mitochondrial dysfunction and apoptosis of cardiocytes. This study aimed to elucidate the activity of
l-carnitine in the prevention on fatty acid-induced mitochondrial membrane permeability transition and cytochrome
c release using isolated cardiac mitochondria from rats. Palmitoyl-CoA-induced mitochondrial respiration that was observed with
l-carnitine was inhibited with oligomycin. The palmitoyl-CoA-induced mitochondrial membrane depolarization and swelling were greatly inhibited by the presence of
l-carnitine. In ultrastructural observations, terminally swollen and ruptured mitochondria with little or no distinguishable cristae structures were induced by treatment with palmitoyl-CoA. However, the severe morphological damage in cardiac mitochondria was dramatically inhibited by pretreatment with
l-carnitine. Treatment with
l-carnitine also attenuated 4-hydroxy-
l-phenylglycine- and rotenone-induced mitochondrial swelling even when the
l-carnitine could not protect against the decrease in oxygen consumption associated with these inhibitors. Furthermore,
l-carnitine completely inhibited palmitoyl-CoA-induced cytochrome
c release. We concluded that
l-carnitine is essential for cardiac mitochondria to attenuate the membrane permeability transition, and to maintain the ultrastructure and membrane stabilization, in the presence of high fatty acid β-oxidation. Consequently, the cells may be protected against apoptosis by
l-carnitine through inhibition of the fatty acid-induced cytochrome
c release.